Canada · Delayed Price · Currency is CAD Diagnamed Holdings Company Description
Diagnamed Holdings Corp. engages in the development and commercialization of AI healthcare solutions.
The company focuses on developing BRAIN AGE BRAIN HEALTH, a brain health AI platform leveraging that aims to predict and monitor brain age and provide actionable insights for mental health and neurodegenerative disorders.
It also engages in exploration of Colchester East Natural Hydrogen Project comprising of 2,104 claims located within the Cumberland Basin in Nova Scotia; and the Timiskaming District of northern Ontario.
It has a collaboration agreement with EIREX for the development and commercialization of EIREX’s novel modular carbon-free technology that extracts hydrogen from water.
Diagnamed Holdings Corp. is headquartered in Toronto, Canada.
| Country | Canada |
| Industry | Health Information Services |
| Sector | Healthcare |
| CEO | John Karagiannidis |
Contact Details
Address: 82 Richmond Street East Toronto, ON M5C 1P1 Canada | |
| Phone | 416 800 2684 |
| Website | diagnamed.com |
Stock Details
| Ticker Symbol | DMED |
| Exchange | Canadian Securities Exchange |
| Fiscal Year | October - September |
| Reporting Currency | CAD |
| ISIN Number | CA25245D1033 |
| SIC Code | 7372 |
Key Executives
| Name | Position |
|---|---|
| John Karagiannidis | President, Chief Executive Officer and Director |
| Andre Turmel | Independent Executive Chairman |
| Edward Low | Interim Chief Financial Officer |
| Andrew Newbury CPA | Corporate Secretary |